ArticleBiomimetics (Basel, Switzerland)2025
FRNet V2: A Lightweight Full-Resolution Convolutional Neural Network for OCTA Vessel Segmentation.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Morphology-aware distillation for lightweight retinal vessel segmentation across fundus photography and OCT angiography.Frontiers in cell and developmental biology · 2026Article
- Vision-language semantic guidance and topology refinement for robust retinal vessel segmentation and biomarker analysis in cerebral small vessel disease.Frontiers in cell and developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Optical coherence tomography angiography (OCTA) is an advanced non-invasive imaging technique that can generate three-dimensional images of retinal and choroidal vessels. It is of great value in the diagnosis and monitoring of a variety of ophthalmic diseases. However, most existing methods for blood vessel segmentation in OCTA images rely on an encoder-decoder architecture. This architecture typically involves a large number of parameters and leads to slower inference speeds. To address these challenges and improve segmentation efficiency, this paper proposes a lightweight full-resolution convolutional neural network named FRNet V2 for blood vessel segmentation in OCTA images. FRNet V2 combines the ConvNeXt V2 architecture with deep separable convolution and introduces a recursive mechanism. This mechanism enhances feature representation while reducing the amount of model parameters and computational complexity. In addition, we design a lightweight hybrid adaptive attention mechanism (DWAM) that further improves the segmentation accuracy of the model through the combination of channel self-attention blocks and spatial self-attention blocks. The experimental results show that on two well-known retinal image datasets (OCTA-500 and ROSSA), FRNet V2 can achieve Dice coefficients and accuracy comparable to other methods while reducing the number of parameters by more than 90%. In conclusion, FRNet V2 provides an efficient and lightweight solution for fast and accurate OCTA image blood vessel segmentation in resource-constrained environments, offering strong support for clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.